1 Min Read
May 3 (Reuters) - AGC Biologics:
* AGC BIOLOGICS SAYS ENTERS INTO COMMERCIAL MANUFACTURING AGREEMENT WITH HORIZON PHARMA PLC FOR COMMERCIAL SUPPLY OF TEPROTUMUMAB Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.